Immune prognostic risk score model in acute myeloid leukemia with normal karyotype
Authors:
- 23 October 2020
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 20 (6) , 1
Abstract
Acute myeloid leukemia with normal karyotype (NK‑AML) is a group of diseases with high heterogeneity and immunological processes are significantly associated with its initiation and development. The implication of the immunogenomic landscape in the prognosis of patients with NK‑AML has remained largely elusive. In the present study, the expression profiles of immune‑related genes (IRGs) were examined and their association with overall survival (OS) was determined in 60 patients with NK‑AML from The Cancer Genome Atlas dataset and 104 patients from the Gene Expression Omnibus (GEO) dataset no. GSE71014. Univariate Cox regression analysis was used to identify 42 and 203 IRGs in the two respective cohorts, which were significantly associated with OS in NK‑AML. A risk model was constructed based on the regression coefficient and expression values of nine survival‑associated IRGs shared between the two datasets [zinc finger CCCH‑type containing, antiviral 1 like; transferrin receptor; suppressor of cytokine signaling 1; ELAV like RNA binding protein 1; roundabout guidance receptor 3; unc‑93 homolog B1, Toll‑like receptor signaling regulator; protein tyrosine phosphatase non‑receptor type 6; interleukin 2 receptor subunit alpha (IL2RA) and IL3RA]. Using this risk model, patients with NK‑AML may be divided into high‑ and low‑risk groups in prognostic predictions. The area under the receiver operating characteristic curve for predicting OS was 0.793. The prognostic role of this risk model was successfully verified in another independent cohort (GEO dataset no. GSE71014). The prognostic risk score was positively associated with age and fms related receptor tyrosine kinase 3 mutation and correlated with infiltration by T regulatory cells. In conclusion, the results of the present study provided an IRG score model for prognostic stratification of adult patients with NK‑AML, as well as further insight into the implication of IRGs in NK‑AML that may lead to the development of novel immunotherapy approaches for this disease.Keywords
This publication has 41 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: Correlation with poor prognosis and CD4 expression on blast cellsCancer Epidemiology, 2012
- Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemiaBlood, 2010
- Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AMLEuropean Journal of Cancer, 2009
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous LeukemiaClinical Cancer Research, 2009
- Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factorsMolecular Cancer Therapeutics, 2008
- Assessing the function of human UNC-93B in Toll-like receptor signaling and major histocompatibility complex II responseHuman Immunology, 2007
- Functional expression of the CD163 scavenger receptor on acute myeloid leukemia cells of monocytic lineageJournal of Leukocyte Biology, 2005
- Interleukin-3 receptor in acute leukemiaLeukemia, 2003
- Inhibition of Retroviral RNA Production by ZAP, a CCCH-Type Zinc Finger ProteinScience, 2002